DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR MEBENDAZOLE

« Back to Dashboard

All Clinical Trials for Mebendazole

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00116493	Severe Anemia Treatment Trials, Pakistan	Completed	Aga Khan University	Phase 3	2004-04-01	The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
NCT00116493	Severe Anemia Treatment Trials, Pakistan	Completed	Johns Hopkins Bloomberg School of Public Health	Phase 3	2004-04-01	The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.
NCT01050452	Safety and Efficacy of Drug Combinations Against Trichuris Trichiura	Completed	DBL -Institute for Health Research and Development	N/A	2007-10-01	This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.
NCT01173562	A Safety Study of Mebendazole in Children 2 to 10 Years of Age	Completed	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3	2010-02-01	The purpose of this study is to assess the safety and tolerability of mebendazole 500-mg chewable tablet formulation in a pediatric population. Mebendazole is a drug used for the treatment of soil-transmitted parasitic helminth (STH) (ie, parasitic worm) infections such as pinworm, whipworm, common roundworm, common hookworm, and American hookworm.

Clinical Trial Conditions for Mebendazole

Condition Name

Condition Name for Mebendazole
Intervention	Trials
Helminthiasis	3
Hookworm Infections	2
Anaplastic Astrocytoma	2
Anemia	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Mebendazole
Intervention	Trials
Infection	6
Helminthiasis	6
Communicable Diseases	5
Hookworm Infections	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Mebendazole

Trials by Country

Trials by Country for Mebendazole
Location	Trials
Tanzania	4
Ethiopia	3
United States	3
Egypt	2
Uganda	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Mebendazole
Location	Trials
Maryland	2
New York	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Mebendazole

Clinical Trial Phase

Clinical Trial Phase for Mebendazole
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	6
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Mebendazole
Clinical Trial Phase	Trials
Completed	14
Recruiting	7
Not yet recruiting	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Mebendazole

Sponsor Name

Sponsor Name for Mebendazole
Sponsor	Trials
Swiss Tropical & Public Health Institute	3
Bill and Melinda Gates Foundation	3
University Ghent	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Mebendazole
Sponsor	Trials
Other	64
Industry	7
NIH	1

Export unavailable in trial.
Subscribe for complete access.